WallStreetZenWallStreetZen

NASDAQ: MYGN
Myriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Myriad Genetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Benjamin Richard WheelerChief Financial Officer2026-03-22549$4.58
$2.51kSell
Dale MuzzeyChief Scientific Officer2026-03-222,019$4.58
$9.25kSell
Mark VerrattiChief Operating Officer2026-03-222,055$4.58
$9.41kSell
Mark VerrattiChief Operating Officer2026-03-159,096$4.66
$42.39kSell
Kevin Richard HaasChief Technology Officer2026-03-158,382$4.66
$39.06kSell
Benjamin Richard WheelerChief Financial Officer2026-03-152,192$4.66
$10.21kSell
Benjamin Richard WheelerChief Financial Officer2026-03-15877$4.66
$4.09kSell
Mark VerrattiChief Operating Officer2026-03-155,611$4.66
$26.15kSell
Kevin Richard HaasChief Technology Officer2026-03-153,355$4.66
$15.63kSell
Dale MuzzeyChief Scientific Officer2026-03-154,783$4.66
$22.29kSell

1 of 4

MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MYGN insiders and whales buy or sell their stock.

MYGN Shareholders

What type of owners hold Myriad Genetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.37%15,303,850$72.69MInstitution
Vanguard Group Inc8.80%8,225,371$39.07MInstitution
Millennium Management LLC7.17%6,700,158$31.83MInstitution
State Street Corp6.38%5,966,567$28.34MInstitution
Glenview Capital Management LLC4.91%4,587,407$21.79MInstitution
D E Shaw Co Inc4.82%4,505,193$21.40MInstitution
Morgan Stanley3.86%3,607,789$17.14MInstitution
Jacobs Levy Equity Management Inc2.43%2,270,378$10.78MInstitution
Geode Capital Management LLC2.39%2,231,292$10.60MInstitution
Goldman Sachs Group Inc 12.31%2,160,282$10.26MInstitution

1 of 3

MYGN vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MYGN89.76%10.24%Net SellingNet Selling
ACRS56.41%43.59%Net SellingNet Selling
FLGT57.16%41.96%Net SellingNet Selling
LAB49.23%50.77%Net BuyingNet Buying
PRE10.85%8.69%
View Top Diagnostic & Research Stocks

Myriad Genetics Stock Ownership FAQ

Who owns Myriad Genetics?

Myriad Genetics (NASDAQ: MYGN) is owned by 98.62% institutional shareholders, 11.25% Myriad Genetics insiders, and 0.00% retail investors. Samraat S. Raha is the largest individual Myriad Genetics shareholder, owning 1.06M shares representing 1.14% of the company. Samraat S. Raha's Myriad Genetics shares are currently valued at $4.97M.

If you're new to stock investing, here's how to buy Myriad Genetics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.